Cavernous Sinus Thrombosis

• Bacterial seeding and inflammation of the cavernous sinus: The process begins when bacteria reach the cavernous sinus through direct extension (from contiguous sinusitis, otitis, or mastoiditis) or retrograde thrombophlebitis via afferent vessels. The rich venous anastomoses of the head and face—particularly the ophthalmic veins, facial veins, and pterygoid plexus—lack valves, allowing bidirectional flow and retrograde spread of infection. Once bacteria inoculate the cavernous sinus, they trigger an intense inflammatory response with upregulation of tissue factor (TF) and activation of the extrinsic coagulation pathway. Endothelial damage from bacterial toxins and inflammatory mediators (TNF-α, IL-1β, IL-6) causes increased vascular permeability and adherence of activated platelets and leukocytes to the vessel wall.

• Septic thrombophlebitis and thrombosis formation: The combination of endothelial injury, inflammatory activation, and stasis of blood within the confined dural space creates a prothrombotic milieu. Bacteria and inflammatory mediators activate the tissue factor pathway, leading to thrombin generation and conversion of fibrinogen to fibrin. Platelets aggregate on damaged endothelium, and leukocytes become trapped within forming thrombi. This process is distinct from aseptic thrombosis because viable bacteria are incorporated into the thrombus, creating a septic focus. The resulting thrombosis obstructs venous outflow from the orbit and intracranial structures, increasing intracranial pressure and compromising perfusion to the cranial nerves that traverse the cavernous sinus (CN III, IV, VI, and branches of CN V).

• Cranial nerve dysfunction from mass effect and inflammatory edema: The cavernous sinus contains the oculomotor nerve (CN III), trochlear nerve (CN IV), abducens nerve (CN VI), and the ophthalmic (V1) and maxillary (V2) divisions of the trigeminal nerve, all coursing through the lateral wall of the sinus. Expansion of the thrombotic and inflammatory mass compresses these nerves against the rigid dural walls, causing demyelination and axonal injury. The inflammatory edema extends into the orbital compartment, increasing intraorbital pressure and causing proptosis, chemosis, and ophthalmoplegia. CN VI, the most medial and least protected nerve, is typically affected first and most severely. The pattern of CN involvement—initially CN VI, then III and IV, progressing to V1 and V2—reflects the anatomic position of nerves within the sinus and is a characteristic clinical signature.

• Venous congestion and orbital manifestations: The thrombotic obstruction of the superior and inferior ophthalmic veins prevents normal venous drainage from the orbit, resulting in venous congestion, increased orbital pressure, and progressive exophthalmos. This mechanism explains the early and prominent orbital signs (proptosis, chemosis, ophthalmoplegia) that may precede systemic toxicity. The congestion impairs microvascular perfusion of the retina and optic nerve, predisposing to optic nerve ischemia and vision loss if untreated. Additionally, backward transmission of increased pressure through the vein of Galen and internal cerebral veins may further elevate intracranial pressure and worsen cerebral perfusion.

• Systemic inflammatory response and sepsis: Beyond local effects, the infected thrombus serves as a continuous source of bacterial endotoxins and antigens that trigger systemic inflammation. Circulating endotoxin activates macrophages and endothelial cells throughout the body, producing massive amounts of TNF-α and IL-1β. This systemic inflammatory response manifests as high fever, leukocytosis, elevated inflammatory markers (ESR, CRP), and can progress to septic shock. Septic emboli can disseminate to distant sites, causing pneumonia, abscess formation, or endocarditis, particularly with virulent organisms like Staphylococcus aureus.

• Paranasal sinusitis (most common modern cause): Acute or chronic infection of the maxillary, ethmoid, or sphenoid sinuses accounts for 40-50% of contemporary cases. The infection spreads either through direct erosion of the sinus wall or retrograde thrombophlebitis via ophthalmic veins. Ethmoid sinusitis is particularly common in children, while sphenoid sinusitis directly abuts the cavernous sinus. Diabetic patients with diabetic ketoacidosis (DKA) are at particular risk for fulminant rhino-orbital-cerebral mucormycosis affecting the cavernous sinus.

• Facial infections and the "danger triangle": The facial area bounded by the nose medially and the angles of the mandible laterally (the "danger triangle" extending from the medial canthus of the eyes to the corners of the mouth) drains via the ophthalmic and facial veins directly to the cavernous sinus without intervening lymph nodes. Infections in this area—including folliculitis, furuncles, impetigo, or even aggressive acne with manipulation—can cause septic thrombophlebitis via retrograde spread. Classic teaching emphasizes that squeezing a pimple on the nose or upper lip can lead to CST, though modern antibiotic use has made this a rare presentation.

• Otitis media and mastoiditis: Infection of the middle ear or mastoid bone can erode through the petrous bone and directly involve the cavernous sinus, or spread via the pterygoid venous plexus. This represents a second common source historically and remains important in patients with chronic suppurative otitis media or inadequate otologic drainage.

• Dental infections and oral sources: Infections of the upper teeth, particularly involving the maxillary molars, can spread to the maxillary sinus and subsequently to the cavernous sinus. Periodontal abscesses and infected tooth sockets are less common but documented sources.

• Staphylococcus aureus (including methicillin-resistant strains): This is the most common isolated pathogen in modern series, accounting for 50-70% of cases. S. aureus produces multiple virulence factors including α-toxin, protein A, and leukocidins that promote bacterial survival and tissue invasion. MRSA prevalence is rising, particularly in hospital-acquired cases, necessitating appropriate empiric coverage with vancomycin or linezolid.

• Streptococcus species: Both aerobic streptococci (particularly Streptococcus pyogenes) and anaerobic streptococci are common culprits. These organisms are frequently part of orofacial and sinusitis flora.

• Gram-negative organisms: Pseudomonas aeruginosa, Klebsiella pneumoniae, and other gram-negative rods are increasingly encountered, particularly in immunocompromised hosts, patients with diabetes, or those with hospital-acquired infections.

• Anaerobic bacteria: Bacteroides, Peptostreptococcus, and other anaerobes are frequently isolated, particularly in odontogenic infections and cases involving aspiration. These are often part of mixed infections.

• Fungal pathogens in immunocompromised hosts: Aspergillus fumigatus and Mucor species cause CST primarily in hematologic malignancy patients, transplant recipients, and severely immunosuppressed individuals. Mucormycosis of the rhinocerebral tract carries extraordinarily high mortality and requires aggressive surgical debridement in addition to antifungal therapy.

• Predisposing conditions: Diabetes mellitus (particularly with DKA), immunosuppression (HIV/AIDS, chemotherapy, transplantation), chronic alcoholism, malnutrition, and previous facial/nasal surgery increase risk. Diabetic patients are susceptible to fulminant mucormycosis. Patients with hematologic malignancies receiving chemotherapy are at risk for Aspergillus and other opportunistic infections.

• High fever and systemic toxicity: Patients typically present with high fever (often >39°C [102°F]), chills, and signs of severe systemic infection. Fever reflects the continuous bacteremia from the infected thrombus and represents the earliest symptom in many cases. Malaise, headache, and myalgias accompany the fever and reflect the systemic inflammatory response. Some patients develop septic shock with hypotension and multiorgan dysfunction, particularly if the primary source is not rapidly controlled.

• Unilateral orbital signs progressing to bilateral: The cardinal early finding is unilateral proptosis (eye protrusion), which is caused by venous congestion and orbital edema from impaired venous drainage. Chemosis (conjunctival edema) is typically pronounced and may be the most obvious sign. Periorbital edema and erythema create a characteristic appearance. These orbital signs develop over hours to days and are often preceded by symptoms of the primary infection (facial lesion, sinus pain, ear drainage). Progression to the contralateral eye occurs in 50-80% of cases as infection spreads through intercavernous sinuses or as thrombosis extends, reflecting the severity of the infection.

• Ophthalmoplegia with characteristic pattern of cranial nerve involvement: The classic progression follows the anatomic position of nerves in the sinus. CN VI (abducens) palsy is typically the earliest sign, manifesting as inability to abduct the affected eye and the development of esotropia. This occurs because CN VI is the most medial and least protected nerve coursing through the sinus. As disease progresses, CN III (oculomotor) and CN IV (trochlear) involvement develop, causing ptosis, impaired adduction and elevation of the eye, and mydriasis (in CN III involvement). The patient's eye becomes fixed in a "down-and-out" position. In severe cases, CN V involvement (V1 and V2 branches) produces loss of corneal reflex and forehead/cheek sensory loss, respectively. Importantly, CN II (optic nerve) is usually spared early because it is located more medially within the orbit; however, optic nerve ischemia can develop from venous congestion or increased intracranial pressure.

• Headache and meningeal signs: A severe headache often accompanies CST and reflects increased intracranial pressure from venous obstruction and cerebral edema. The headache is often frontal or retro-orbital and worsens with head movement. Meningeal signs (neck stiffness, photophobia) may develop due to associated meningitis from septic emboli, particularly in cases originating from paranasal sinusitis. The presence of meningeal signs should prompt lumbar puncture (after excluding mass effect) and CSF analysis.

• Vision loss: Decreasing visual acuity occurs in 10-20% of cases and results from optic nerve ischemia due to venous congestion, increased intracranial pressure, or direct inflammation. Patients may report photopsia (flashing lights) or scotomas. Amaurosis fugax (transient vision loss) may precede complete vision loss. Fundoscopic examination may reveal papilledema (from increased ICP), retinal hemorrhages, or optic disc pallor.

• Seizures: Occur in 10-15% of cases and result from cortical irritation from edema, inflammation, or venous infarction. Seizures may be focal (reflecting the distribution of thrombosis) or generalized. Post-ictal confusion is common.

• Altered mental status and focal neurologic deficits: Altered consciousness, confusion, or delirium reflects high fever, sepsis, increased intracranial pressure, and direct brain involvement. Focal deficits (hemiparesis, hemisensory loss) occur if extension into the brain parenchyma causes stroke or abscess formation. This is an ominous sign portending worse prognosis.

• Physical examination pearls: Beyond the constellation of orbital signs, careful examination should focus on identifying the primary source of infection. Examine the face carefully for any lesion in the "danger triangle." Inspect and palpate the paranasal sinuses (maxillary tenderness over the cheek, ethmoid tenderness between the eyes, sphenoid tenderness behind the nose). Otoscopy should evaluate for otitis media or mastoiditis. Intraoral examination should identify dental pathology or periodontal disease. Test extraocular movements systematically and document any deficits. Assess visual acuity and color vision. Perform careful fundoscopy. Check for papilledema, which suggests increased ICP. Examine for signs of systemic infection: tachycardia, tachypnea, hypotension, altered mental status.

• Important clinical variants: Some presentations may be atypical. Septic cavernous sinus thrombosis can present with minimal orbital signs but prominent systemic toxicity and meningitis, particularly with hematogenous seeding from distant sources (endocarditis, pneumonia). Tolosa-Hunt syndrome (granulomatous inflammation of the cavernous sinus) presents with similar orbital signs but lacks fever and systemic toxicity, making clinical differentiation crucial. Aseptic thrombosis (from malignancy, hypercoagulability, or inflammatory conditions like sarcoidosis) lacks fever and systemic signs. Anterior versus posterior cavernous sinus disease may affect which cranial nerves are involved earliest.

• Clinical diagnosis: CST should be suspected in any patient with fever, proptosis, ophthalmoplegia (particularly with CN VI palsy), chemosis, and periorbital edema, especially if there is an identifiable source of infection (sinusitis, facial lesion, otitis). The development of bilateral orbital signs is highly suggestive. However, no single sign or symptom is pathognomonic, and some cases are diagnosed only after the patient deteriorates clinically. High clinical suspicion should prompt immediate imaging rather than waiting for laboratory confirmation.

• Complete blood count (CBC): Marked leukocytosis with left shift (WBC typically 15,000-30,000/μL) is characteristic and reflects the intense systemic inflammatory response. The presence of immature bands indicates severe infection. However, immunocompromised patients may have blunted leukocytic response. Anemia may develop from chronic infection or septic emboli.

• Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP): Both are markedly elevated (ESR often >50 mm/hr, CRP often >100 mg/L) due to systemic inflammation. While nonspecific, severely elevated values support the diagnosis. These markers normalize over weeks with successful treatment and can be used to guide duration of therapy.

• Blood cultures: Should be obtained immediately in all suspected cases, as they are positive in 50-80% of cases and identify the causative organism and antibiotic sensitivities. Multiple sets should be obtained before antibiotics are started, though empiric antibiotics should not be delayed. Culture results guide transition from empiric to targeted therapy. Cultures should be held for extended periods (at least 2 weeks) as fastidious organisms may grow slowly.

• Lumbar puncture and cerebrospinal fluid (CSF) analysis: Should be performed if meningitis is suspected (meningeal signs, altered mental status, seizures) and after imaging excludes mass effect or increased ICP. CSF in CST shows pleocytosis with predominance of polymorphonuclear leukocytes (PMNs), elevated protein (often >100 mg/dL), and normal to low glucose. Gram stain and culture of CSF may reveal the causative organism, particularly in Streptococcus or Haemophilus species. However, CSF may be sterile even in cases where blood cultures are positive, as the infection is primarily in the dural venous space rather than the subarachnoid space.

• **Magnetic

Immediate stabilization

• Sepsis resuscitation: draw blood cultures, then give IV crystalloid and, if hypotension persists, a vasopressor (norepinephrine first-line per the Surviving Sepsis Campaign). Secure the airway if mental status is deteriorating. In diabetic patients, correct ketoacidosis with an insulin infusion — persistent acidosis and hyperglycemia perpetuate mucormycosis risk.
• Do not delay antimicrobials for imaging: empiric therapy starts within the first hour of suspicion; MRI/MRV can follow.

First-line antimicrobial therapy

• Anti-MRSA glycopeptide: vancomycin, dosed to a 24-hour AUC with a target AUC/MIC of 400–600 (2020 IDSA/ASHP/PIDS/SIDP consensus). Linezolid or daptomycin are alternatives; daptomycin is inactive in the lung if septic pulmonary emboli are present.
• CNS-penetrating beta-lactam: ceftriaxone, escalated to cefepime or meropenem when Pseudomonas, nosocomial acquisition, or immunosuppression is suspected.
• Anaerobic coverage: metronidazole, essential for odontogenic and chronic sinus/otogenic sources.
• De-escalate on culture data: for MSSA, an antistaphylococcal penicillin (nafcillin) or cefazolin outperforms vancomycin. Prolonged IV therapy — generally on the order of several weeks and continued beyond clinical and radiographic resolution — is standard.

Adjunctive and escalation options

• Anticoagulation: unfractionated heparin or LMWH is commonly used; the AHA/ASA scientific statement on cerebral venous thrombosis supports anticoagulation for CVT even with venous hemorrhagic infarction, though data specific to septic cavernous sinus thrombosis are retrospective and contested.
• Corticosteroids: dexamethasone is sometimes added for cranial-nerve edema or pituitary insufficiency, only after effective antimicrobials; evidence is weak and non-guideline-based.
• Fungal disease: liposomal amphotericin B plus urgent debridement for mucormycosis (ECMM/MSG-ERC guidance); voriconazole for Aspergillus (IDSA). Isavuconazole/posaconazole are step-down or salvage options.

Ophthalmologic (sight-threatening emergencies)

• Permanent vision loss/blindness: venous congestion and raised orbital pressure produce optic nerve or retinal ischemia; signaled by falling visual acuity, a relative afferent pupillary defect, or red desaturation. Central retinal vein occlusion gives blood-and-thunder fundus; emergent ophthalmology consultation.
• Orbital compartment syndrome: tense proptosis with rising intraocular pressure — an emergency that may require lateral canthotomy/cantholysis.

Intracranial extension (emergencies)

• Meningitis, subdural empyema, brain abscess: contiguous or embolic spread; heralded by new seizures, focal deficits, or declining consciousness. Any of these mandates urgent contrast imaging.
• Internal carotid artery injury: the ICA runs inside the sinus, so inflammatory arteritis can cause luminal narrowing, thrombosis with ischemic stroke, or a mycotic pseudoaneurysm that ruptures into the sinus (carotid-cavernous fistula: pulsatile proptosis with an orbital bruit).
• Cortical venous infarction with hemorrhage: outflow obstruction raises venous pressure; presents as seizure plus focal deficit.

Endocrine and systemic

• Pituitary insufficiency: the gland sits medial to the sinus and may infarct — hypotension refractory to fluids, hyponatremia, hypoglycemia. Check cortisol; give stress-dose hydrocortisone.
• Septic pulmonary emboli / metastatic abscess / endocarditis: S. aureus thrombus fragments; new hypoxemia with peripheral cavitating nodules.
• Septic shock and DIC: hypotension, thrombocytopenia, prolonged INR.

Treatment-related

• Anticoagulation: hemorrhagic conversion of venous infarct; heparin-induced thrombocytopenia (platelet fall after roughly 5–10 days).
• Vancomycin: acute kidney injury, higher with concomitant piperacillin-tazobactam; infusion reaction.
• Amphotericin B: nephrotoxicity with hypokalemia and hypomagnesemia.
• Corticosteroids/broad antibiotics: hyperglycemia, C. difficile colitis.

• Bilateral orbital signs are the discriminator: unilateral proptosis and chemosis that cross to the other eye through the intercavernous sinuses essentially exclude orbital cellulitis, the favorite distractor. Orbital cellulitis stays unilateral and does not cause multiple cranial neuropathies.
• CN VI palsy first: the abducens nerve runs free within the sinus lumen beside the carotid, while III, IV, V1, and V2 sit in the lateral dural wall. An isolated lateral rectus palsy with fever and proptosis is the classic opener.
• V3 is spared: the mandibular division exits via foramen ovale and never enters the sinus. Forehead (V1) and cheek (V2) numbness with intact jaw sensation localizes the lesion precisely — this is the anatomy examiners test most.
• Horner syndrome plus CN VI palsy localizes to the cavernous sinus, because the postganglionic sympathetic fibers travel on the carotid there. CN II is not in the sinus, so early vision loss is ischemic, not compressive.
• Best next step: blood cultures followed immediately by empiric IV vancomycin plus a CNS-penetrating beta-lactam and metronidazole, then contrast-enhanced MRI with MR venography. Never delay antibiotics for the scan.
• **The organism to name is *Staphylococcus aureus***, usually from sphenoid/ethmoid sinusitis or a danger triangle furuncle drained by valveless facial and ophthalmic veins.
• DKA or neutropenia plus black nasal turbinate eschar = rhino-orbital-cerebral mucormycosis: liposomal amphotericin B and emergent surgical debridement, not antibiotics alone.
• Distractor to reject: Tolosa-Hunt syndrome — painful ophthalmoplegia that is afebrile, culture-negative, and steroid-responsive. Treating a febrile, toxic patient with steroids alone is the wrong answer.
• Vancomycin is dosed to a 24-hour AUC/MIC of 400–600 (2020 IDSA/ASHP consensus); the old 15–20 mcg/mL trough goal is retired.